Incidence and Causes of Hospital Readmission in Pediatric Patients after Hematopoietic Cell Transplantation

AbstractAllogeneic (allo) and autologous (auto) hematopoietic cell transplantation (HCT) provide the potential to cure otherwise fatal diseases but they are resource-intense therapies. There is scant literature describing the burden of hospital readmission in the critical 6-month period of immunosuppression after HCT. We report the incidence, causes, and outcomes of readmission in the 6 months after day 0 of HCT and in the 30 days after hospital discharge. This study is an institutional review board–approved retrospective medical record review of children who underwent HCT at a single institution. Between January 1, 2008 and December 31, 2011, 291 children underwent HCT at our institute. Of these, 140 patients were excluded because they were not followed primarily at our institute for the first 6 months after transplantation, 14 patients were excluded because they died during their initial hospitalization, and 1 patient was excluded because the initial hospitalization was longer than 6 months. Of the remaining 136 patients, 63% had at least 1 readmission. Of the patients who underwent allo-HCT, 78% were readmitted, in contrast to 38% of auto-HCT patients (P < .001). For the 206 readmissions, the mean length of hospital stay was 10.7 days (range, 1 to 129). Seventy-two percent of auto-HCT patients were initially readmitted for fever, and 46% ultimately had a source identified. No risk factors for readmission were found in the auto-HCT group. Fifty-two percent of allo-HCT patients were readmitted for fever and 28% of these patients ultimately had an identified source. Gastrointestinal-related problems accounted for 30% of primary readmissions among allo-HCT patients. Patients with an unrelated donor had a trend towards increased rates of 30-day readmission (P = .06) and were more likely to have a second readmission (P = .002). Patients who were cytomegalovirus (CMV) positive before transplantation were more likely to be readmitted (P = .02). The majority of children who undergo HCT are readmitted during the critical 180 days after transplantation. Readmission is much more common among allo-HCT patients, in particular those with unrelated donors and CMV-positive serologies before transplantation. Fever is the most common cause of readmission in these patients, and serious infections are identified in a significant portion of patients. These findings and future research in this area will help improve both patient education and resource utilization

Identifying recycled materials using Mo Isotopes in intraplate alkali basalts from the southeastern margin of Tibetan Plateau

Mantle heterogeneity in lithology and geochemistry is often attributed to recycled subducted materials. While distinct mantle end‐members are identified by radiogenic isotopes, the specific recycled materials contributing to this heterogeneity remain debated. This study presents Mo‐Sr‐Nd‐Pb isotopic data for OIB‐like alkali basalts from the Maguan area in the southeastern Tibetan Plateau, focusing on slab inputs' role in mantle heterogeneity. The Miocene (ca. 13 Ma) Maguan alkali basalts are divided into two types based on petrographic and geochemical characteristics, showing similar Sr‐Nd‐Pb isotopic signatures but different Mo isotopic compositions. Type I basalts exhibit a wide δ98/95Mo range (−0.31‰ to −1.03‰, average −0.47‰ ± 0.06‰, 2SD = 0.40‰, n = 13), while type II basalts have heavy and constant δ98/95Mo values (−0.11‰ to −0.17‰, average −0.14‰ ± 0.01‰, 2SD = 0.05‰, n = 6). The unique low δ98/95Mo value (−1.03‰) in type I basalts is among the lowest reported in OIB‐like continental basalts. Type I basalts likely originate from an enriched asthenospheric mantle metasomatized by melts from recycled dehydrated oceanic crust and sediments, whereas type II basalts are derived from partial melting of an enriched asthenospheric mantle metasomatized by melts from recycled serpentinized peridotites. The residual Tethys oceanic slabs in the deep mantle significantly contribute to the mantle source of the Maguan basalts. The formation of Maguan Miocene magmas may be linked to mantle upwelling induced by the subduction of the West Burma plate. This study highlights the Mo isotopic system's utility in tracing complex slab fluxes generating mantle geochemical heterogeneity

Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival

Ependymoma is the third most common brain tumor in children, but there is a paucity of large studies with more than 10 years of follow-up examining the long-term survival and recurrence patterns of this disease. We conducted a retrospective chart review of 103 pediatric patients with WHO Grades II/III intracranial ependymoma, who were treated at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Chicago’s Ann & Robert H. Lurie Children’s Hospital between 1985 and 2008, and an additional 360 ependymoma patients identified from the Surveillance Epidemiology and End Results (SEER) database. For the institutional cohort, we evaluated clinical and histopathological prognostic factors of overall survival (OS) and progression-free survival (PFS) using the log-rank test, and univariate and multivariate Cox proportional-hazards models. Overall survival rates were compared to those of the SEER cohort. Median follow-up time was 11 years. Ten-year OS and PFS were 50 ± 5% and 29 ± 5%, respectively. Findings were validated in the independent SEER cohort, with 10-year OS rates of 52 ± 3%. GTR and grade II pathology were associated with significantly improved OS. However, GTR was not curative for all children. Ten-year OS for patients treated with a GTR was 61 ± 7% and PFS was 36 ± 6%. Pathological examination confirmed most recurrent tumors to be ependymoma, and 74% occurred at the primary tumor site. Current treatment paradigms are not sufficient to provide long-term cure for children with ependymoma. Our findings highlight the urgent need to develop novel treatment approaches for this devastating disease. Electronic supplementary material The online version of this article (doi:10.1007/s11060-017-2568-8) contains supplementary material, which is available to authorized users

Methylprednisolone as Adjunct to Endovascular Thrombectomy for Large-Vessel Occlusion Stroke

Importance It is uncertain whether intravenous methylprednisolone improves outcomes for patients with acute ischemic stroke due to large-vessel occlusion (LVO) undergoing endovascular thrombectomy. Objective To assess the efficacy and adverse events of adjunctive intravenous low-dose methylprednisolone to endovascular thrombectomy for acute ischemic stroke secondary to LVO. Design, Setting, and Participants This investigator-initiated, randomized, double-blind, placebo-controlled trial was implemented at 82 hospitals in China, enrolling 1680 patients with stroke and proximal intracranial LVO presenting within 24 hours of time last known to be well. Recruitment took place between February 9, 2022, and June 30, 2023, with a final follow-up on September 30, 2023.InterventionsEligible patients were randomly assigned to intravenous methylprednisolone (n = 839) at 2 mg/kg/d or placebo (n = 841) for 3 days adjunctive to endovascular thrombectomy. Main Outcomes and Measures The primary efficacy outcome was disability level at 90 days as measured by the overall distribution of the modified Rankin Scale scores (range, 0 [no symptoms] to 6 [death]). The primary safety outcomes included mortality at 90 days and the incidence of symptomatic intracranial hemorrhage within 48 hours. Results Among 1680 patients randomized (median age, 69 years; 727 female [43.3%]), 1673 (99.6%) completed the trial. The median 90-day modified Rankin Scale score was 3 (IQR, 1-5) in the methylprednisolone group vs 3 (IQR, 1-6) in the placebo group (adjusted generalized odds ratio for a lower level of disability, 1.10 [95% CI, 0.96-1.25]; P = .17). In the methylprednisolone group, there was a lower mortality rate (23.2% vs 28.5%; adjusted risk ratio, 0.84 [95% CI, 0.71-0.98]; P = .03) and a lower rate of symptomatic intracranial hemorrhage (8.6% vs 11.7%; adjusted risk ratio, 0.74 [95% CI, 0.55-0.99]; P = .04) compared with placebo. Conclusions and Relevance Among patients with acute ischemic stroke due to LVO undergoing endovascular thrombectomy, adjunctive methylprednisolone added to endovascular thrombectomy did not significantly improve the degree of overall disability.Trial RegistrationChiCTR.org.cn Identifier: ChiCTR210005172

Cost-effective and robust service provisioning in multi-access edge computing

With the development of multiaccess edge computing (MEC) technology, an increasing number of researchers and developers are deploying their computation-intensive and IO-intensive services (especially AI services) on edge devices. These devices, being close to end users, provide better performance in mobile environments. By constructing a service provisioning system at the network edge, latency is significantly reduced due to short-distance communication with edge servers. However, since the MEC-based service provisioning system is resource-sensitive and the network may be unstable, careful resource allocation and traffic scheduling strategies are essential. This paper investigates and quantifies the cost-effectiveness and robustness of the MEC-based service provisioning system with the applied resource allocation and traffic scheduling strategies. Based on this analysis, a c ost- e ffective and r obust service provisioning a lgorithm, termed CERA , is proposed to minimize deployment costs while maintaining system robustness. Extensive experiments are conducted to compare the proposed approach with well-known baseline algorithms and evaluate factors impacting the results. The findings demonstrate that CERA achieves at least 15.9% better performance than other baseline algorithms across various instances.<br/

Predicting the Impact of Climate Change on the Distribution of a Neglected Arboviruses Vector (Armigeres&nbsp;subalbatus) in China

The geographic boundaries of arboviruses continue to expand, posing a major health threat to millions of people around the world. This expansion is related to the availability of effective vectors and suitable habitats. Armigeres&nbsp;subalbatus (Coquillett, 1898), a common and neglected species, is of increasing interest given its potential vector capacity for Zika virus. However, potential distribution patterns and the underlying driving factors of Ar. subalbatus remain unknown. In the current study, detailed maps of their potential distributions were developed under both the current as well as future climate change scenarios (SSP126 and SSP585) based on CMIP6 data, employing the MaxEnt model. The results showed that the distribution of the Ar. subalbatus was mainly affected by temperature. Mean diurnal range was the strongest predictor in shaping the distribution of Ar. subalbatus, with an 85.2% contribution rate. By the 2050s and 2070s, Ar. subalbatus will have a broader potential distribution across China. There are two suitable expansion types under climate change in the 2050s and 2070s. The first type is continuous distribution expansion, and the second type is sporadic distribution expansion. Our comprehensive analysis of Ar. subalbatus&rsquo;s suitable distribution areas shifts under climate change and provides useful and insightful information for developing management strategies for future arboviruses